News
04-08-2008 |
09:43 hs.
Agency Supports Amigal Move to Phase 3; Eligible for Accelerated Approval; Final Global Regulatory Plan Expected by Year End
04-08-2008 |
09:31 hs.
74 percent of patients achieved SVR 12 with 48-week boceprevir-based combination therapy
High SVR 24 rate also reported for 28-week boceprevir arm
High SVR 24 rate also reported for 28-week boceprevir arm
29-07-2008 |
00:55 hs.
29-07-2008 |
00:54 hs.
29-07-2008 |
00:52 hs.
Partnership creates worldwide strategic collaboration between Vivalis and GeoVax
29-07-2008 |
00:50 hs.
29-07-2008 |
00:48 hs.
29-07-2008 |
00:47 hs.
- First and only drug therapy to address major Chinese health concern -
29-07-2008 |
00:45 hs.
29-07-2008 |
00:42 hs.
Aspirin effect testing will be added to lab's advanced cardiovascular assessment services
29-07-2008 |
00:40 hs.
Therapeutic nicotine (TN) remains first-line treatment option
29-07-2008 |
00:38 hs.
--FDA to provide draft labeling in the next few weeks--
29-07-2008 |
00:37 hs.
-- Company Provides Update to Phase 2 Development Plan --
29-07-2008 |
00:36 hs.
29-07-2008 |
00:33 hs.
- Company initiates trial of first-in-class oncology molecule and progresses Aurora A kinase program -
29-07-2008 |
00:32 hs.
29-07-2008 |
00:31 hs.
8-year-old patient receives 'hidden scar' procedure; Pediatrics becomes 4th surgical specialty to benefit from single port surgery with RealHand HD instruments
29-07-2008 |
00:29 hs.
The International AIDS Vaccine Initiative (IAVI) and Key Thought Leaders Explore Critical Next Steps for AIDS Vaccine Research at the 17thInternational AIDS Conference in Mexico City
29-07-2008 |
00:28 hs.
29-07-2008 |
00:26 hs.
When Available in the U.S., ARCHITECT(R) ci4100(TM) Will Complete the ARCHITECT Family of Products, Providing Improved Productivity for Low-Volume-Testing Laboratories
